Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?

View at publisher
Authors: Li‐Tong Lin, Cheng‐Hsien Hung
Cited by: 1
References: 3

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Virus-based gene therapy research Cytomegalovirus and herpesvirus research

Publication details

Journal / source
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Volume
64
Issue
10
Pages
1492-1493
Publication date
9 August 2026
Language
EN